Get started
October Pharma Co.October Pharma Co.October Pharma Co.

October Pharma Co.

No trades
No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with October Pharma Co.



Key stats


Market capitalization
‪6.08 B‬ EGP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪2.82 M‬
Beta (1Y)
0.57

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Hesham Abdul Aziz El Sayed Soliman
Website
octoberpharma.com
Headquarters
Cairo
Founded
1987
IPO date
May 21, 2007
ISIN
EGS380R1C018
FIGI
BBG000JYSJS2
Identifiers
ISIN EGS380R1C018
October Pharma Co. manufactures and distributes pharmaceuticals and drugs. It specializes in ophthalmology preparations. It offers pharmaceutical products for cardiovascular, diabetology, hepatology, dental and urology. The company was founded on April 11, 1987 and is headquartered in Cairo, Egypt.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of OCPH is 251.00 EGP — it has increased by 1.54% in the past 24 hours. Watch October Pharma Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange October Pharma Co. stocks are traded under the ticker OCPH.
OCPH stock has risen by 2.24% compared to the previous week, the month change is a 6.51% rise, over the last year October Pharma Co. has showed a 156.87% increase.
OCPH reached its all-time high on Aug 11, 2026 with the price of 341.99 EGP, and its all-time low was 0.67 EGP and was reached on Sep 18, 2014. View more price dynamics on OCPH chart.
See other stocks reaching their highest and lowest prices.
OCPH stock is 2.73% volatile and has beta coefficient of 0.57. Track October Pharma Co. stock price on the chart and check out the list of the most volatile stocks — is October Pharma Co. there?
Today October Pharma Co. has the market capitalization of ‪6.18 B‬, it has decreased by −1.88% over the last week.
Yes, you can track October Pharma Co. financials in yearly and quarterly reports right on TradingView.
OCPH net income for the last quarter is ‪66.69 M‬ EGP, while the quarter before that showed ‪77.15 M‬ EGP of net income which accounts for 0.00% change. Track more October Pharma Co. financial stats to get the full picture.
Like other stocks, OCPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade October Pharma Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So October Pharma Co. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating October Pharma Co. stock shows the buy signal. See more of October Pharma Co. technicals for a more comprehensive analysis.